Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms

Nosocomial infection, in particular pneumonia, is an important risk factor for hospital mortality and morbidity. Acinetobacter baumanii is a common multi-resistant microorganism responsible of Ventilator Associated Pneumonia (VAP). Currently Colistin is a rescue therapy for this pathogen. The purpos...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Bonito, Marianna, Caiazzo, Simona, Iannazzone, Marta, Miccichè, Viviana, De Marco, Giuseppe, De Robertis, Edoardo, Tufano, Rosalba, Piazza, Ornella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università di Salerno 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728786/
https://www.ncbi.nlm.nih.gov/pubmed/23905048
_version_ 1782278911524077568
author Di Bonito, Marianna
Caiazzo, Simona
Iannazzone, Marta
Miccichè, Viviana
De Marco, Giuseppe
De Robertis, Edoardo
Tufano, Rosalba
Piazza, Ornella
author_facet Di Bonito, Marianna
Caiazzo, Simona
Iannazzone, Marta
Miccichè, Viviana
De Marco, Giuseppe
De Robertis, Edoardo
Tufano, Rosalba
Piazza, Ornella
author_sort Di Bonito, Marianna
collection PubMed
description Nosocomial infection, in particular pneumonia, is an important risk factor for hospital mortality and morbidity. Acinetobacter baumanii is a common multi-resistant microorganism responsible of Ventilator Associated Pneumonia (VAP). Currently Colistin is a rescue therapy for this pathogen. The purpose of this retrospective study is to compare the outcome of VAP caused by Acinetobacter baumanii and VAP from other microorganisms in critical patients. Comorbidity, prognostic scores, mortality and eradication frequency did not turn out significantly different between the two study groups. Colistin safety was tested.
format Online
Article
Text
id pubmed-3728786
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Università di Salerno
record_format MEDLINE/PubMed
spelling pubmed-37287862013-07-31 Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms Di Bonito, Marianna Caiazzo, Simona Iannazzone, Marta Miccichè, Viviana De Marco, Giuseppe De Robertis, Edoardo Tufano, Rosalba Piazza, Ornella Transl Med UniSa Research Article Nosocomial infection, in particular pneumonia, is an important risk factor for hospital mortality and morbidity. Acinetobacter baumanii is a common multi-resistant microorganism responsible of Ventilator Associated Pneumonia (VAP). Currently Colistin is a rescue therapy for this pathogen. The purpose of this retrospective study is to compare the outcome of VAP caused by Acinetobacter baumanii and VAP from other microorganisms in critical patients. Comorbidity, prognostic scores, mortality and eradication frequency did not turn out significantly different between the two study groups. Colistin safety was tested. Università di Salerno 2012-04-30 /pmc/articles/PMC3728786/ /pubmed/23905048 Text en http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Di Bonito, Marianna
Caiazzo, Simona
Iannazzone, Marta
Miccichè, Viviana
De Marco, Giuseppe
De Robertis, Edoardo
Tufano, Rosalba
Piazza, Ornella
Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
title Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
title_full Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
title_fullStr Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
title_full_unstemmed Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
title_short Prognostic differences between VAP from Acinetobacter baumanii and VAP from other microorganisms
title_sort prognostic differences between vap from acinetobacter baumanii and vap from other microorganisms
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728786/
https://www.ncbi.nlm.nih.gov/pubmed/23905048
work_keys_str_mv AT dibonitomarianna prognosticdifferencesbetweenvapfromacinetobacterbaumaniiandvapfromothermicroorganisms
AT caiazzosimona prognosticdifferencesbetweenvapfromacinetobacterbaumaniiandvapfromothermicroorganisms
AT iannazzonemarta prognosticdifferencesbetweenvapfromacinetobacterbaumaniiandvapfromothermicroorganisms
AT miccicheviviana prognosticdifferencesbetweenvapfromacinetobacterbaumaniiandvapfromothermicroorganisms
AT demarcogiuseppe prognosticdifferencesbetweenvapfromacinetobacterbaumaniiandvapfromothermicroorganisms
AT derobertisedoardo prognosticdifferencesbetweenvapfromacinetobacterbaumaniiandvapfromothermicroorganisms
AT tufanorosalba prognosticdifferencesbetweenvapfromacinetobacterbaumaniiandvapfromothermicroorganisms
AT piazzaornella prognosticdifferencesbetweenvapfromacinetobacterbaumaniiandvapfromothermicroorganisms

Ejemplares similares